Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The company is headquartered in Las Vegas, Nevada and currently employs 7 full-time employees. The company went IPO on 2011-12-23. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated, easy-to-handle, tasteless, and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device, and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.
Follow-Up Questions
Who is the CEO of Hypha Labs Inc?
Mr. A. Stone Douglass is the Chairman of the Board of Hypha Labs Inc, joining the firm since 2021.
What is the price performance of FUNI stock?
The current price of FUNI is $0.027, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Hypha Labs Inc?
Hypha Labs Inc belongs to Consumer products industry and the sector is Consumer Discretionary
